Showing 7261-7270 of 8699 results for "".
- Free Skin Health Screenings This Weekendhttps://practicaldermatology.com/news/20130510-free_skin_health_screenings_this_weekend/2459549/In the interest of Skin Cancer Awareness Month, Sam's Clubs nationwide are offering free skin health screenings on Saturday, May 11 from 11am-3pm to members and non members. Those screened are being encouraged to take results to a dermatologist to get proper treatment and advice after their exams. T
- OXY Unveils Overhauled Acne Lineshttps://practicaldermatology.com/news/20130507-oxy_unveils_overhauled_acne_lines/2459550/After 30 years, the OXY brand (Mentholatum Company) has had a makeover and now offers two distinct lines grouped by active ingredients designed to either kill acne (benzoyl peroxide) or provide maintenance for acne-prone skin (salicylic acid). The OXY Maximum Action line includes, among others, OXY
- Pliaglis Launches in Europehttps://practicaldermatology.com/news/20130502-pliaglis_launches_in_europe/2459551/Nuvo Research Inc. and Galderma Pharma, S.A. launched Pliaglis (lidocaine and tetracaine) Cream 7%/7% in Europe. Nuvo has licensed worldwide marketing rights for Pliaglis to Galderma, and licenses have been issued in 14 of the 16 European cou
- Me Smooth Debuts on QVChttps://practicaldermatology.com/news/20130429-me_smooth_debuts_on_qvc/2459557/Syneron Beauty Inc. introduced its new me smooth at-home professional hair removal system on QVC this week. The device includes a travel bag and an additional elos cartridge to deliver effective removal of unwanted hair for all skin tones, accordi
- Anterios CEO to Present at Healthcare Conferencehttps://practicaldermatology.com/news/20130429-anterios_ceo_to_present_at_healthcare_conference/2459558/CEO and Founder of Anterios, Inc., Jon Edelson, MD, will be presenting at Needham & Company's 12th Annual Healthcare Conference in New York City on April 30, 2013. In other company news, Anterios also recently received an $8.5 million round of
- HydraSolve Cleared for Autologous Fat Transferhttps://practicaldermatology.com/news/20130425-hydrasolve_cleared_for_autologous_fat_transfer/2459559/The new Hydrasolve liposuction device has recently been FDA-cleared for autologous fat transfer, a first-of-its-kind indication in the liposuction realm. The new clearance enables clinicians to harvest and re-inject fat from the initial HydraSolve liposuction procedure for rejuvenations or augmentat
- Angela Bennett Appointed as La Roche-Posay VPhttps://practicaldermatology.com/news/20130418-angela_bennett_appointed_as_la_roche-posay_vp/2459561/L'Oréal USA named Angela Bennett the Vice President of La Roche-Posay. A graduate of Loyola University in Baltimore, MD where she earned a degree in Business Administration, Bennett brings a wealth of experience, having worked with many global brands and has established solid relationships wi
- BTL Aesthetics Introduces Exilis Elitehttps://practicaldermatology.com/news/20130415-btl_aesthetics_introduces_exilis_elite/2459563/BTL Aesthetics recently introduced the Exilis ELITE, its next stage device for reducing wrinkles and treating skin laxity of the face and body. Optimizing the dynamic monopolar radiofrequency (RF) technology of the original Exilis system, the new ELITE platformoptimizes the monopolar radiofrequency
- Promius Pharma Introduces Zenatane and “The Promius Promise”https://practicaldermatology.com/news/20130412-promius_pharma_introduces_zenatane_and_the_promius_promise/2459565/Promius Pharma, LLC announced the introduction of Zenatane (Isotretinoin) Capsules, a newly approved isotretinoin option for patients with severe, recalcitrant, nodular acne. Zenatane will be supported by The Promius Promise, a pharmacy serv
- “Dermatologist from the Heart” Program Seeks Grant Proposalshttps://practicaldermatology.com/news/20130410-dermatologist_from_the_heart_program_seeks_grant_proposals/2459567/“Dermatologist from the Heart” is a new program from La Roche-Posay that aims to support initiatives designed to enhance the quality of life for patients. The initiative will award a grant to the most compassionate project spearheaded by dermatologists that seek to enhance patients' quality of life.